theophylline has been researched along with nadp in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (56.52) | 18.7374 |
1990's | 3 (13.04) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 1 (4.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frantsuzova, SB | 1 |
Mahoney, E; Scott, WA | 1 |
Binkley, F; Isaacs, JT | 1 |
Malaisse, WJ; Sener, A | 1 |
Blake, DA; Buterbaugh, GG; Weiner, M | 1 |
Feinstein, M; Halkerston, ID; Hechter, O | 1 |
Senft, G | 1 |
Gilman, AG; Rall, TW | 1 |
Macchia, V; Maselli, P; Meldolesi, MF | 1 |
Fong, CT; Lankau, G; Silver, L | 1 |
Bellino, FL; Hussa, RO | 1 |
Amm, U; Ammon, HP; Eujen, R; Hoppe, E; Trier, G; Verspohl, EJ | 1 |
Couturier, E; Kawazu, S; Malaisse, WJ; Sener, A | 1 |
Ayrton, AD; Chenery, RJ; Clarke, SE | 1 |
Li, CG; Najbar, A; Rand, MJ | 1 |
Dong, MS; Gillam, EM; Guengerich, FP; Johnson, WW; Shimada, T; Yamazaki, H | 1 |
Fernandez, M; Hashemi, E; Ioannides, C; Lewis, DF; Papagiannidou, E; Skene, DJ; Snelling, J | 1 |
Abolfathi, Z; Beaune, P; Labbé, L; Lessard, E; Pakdel, H; Turgeon, J | 1 |
Fouda, HG; Khojasteh-Bakht, SC; Prakash, C; Rossulek, MI | 1 |
Clay, CD; Dalton, TP; Genter, MB; Nebert, DW; Schneider, SN; Shertzer, HG | 1 |
Chapple, S; Collins, C; Fairman, DA | 1 |
Pietrzak, M; Szelag, M; Wierzchowski, J; Wroczyński, P | 1 |
Farid, NA; Hagihara, K; Ikeda, T; Ishizuka, T; Kazui, M; Kurihara, A; Nishiya, Y; Okazaki, O | 1 |
1 review(s) available for theophylline and nadp
Article | Year |
---|---|
Hormonal control of carbohydrate and lipid metabolism and drug induced alterations.
Topics: Adenine Nucleotides; Animals; Carbohydrate Metabolism; Cyclic AMP; Epinephrine; Furosemide; Gluconeogenesis; Glutathione; Glutathione Reductase; Isocitrate Dehydrogenase; Kidney; Lipid Metabolism; Lyases; NADP; Natriuresis; Oxidoreductases; Phentolamine; Propranolol; Theophylline; Vasopressins; Water-Electrolyte Balance | 1968 |
22 other study(ies) available for theophylline and nadp
Article | Year |
---|---|
[Level of nicotinamide coenzymes in the myocardium of rats during the effects of methylxanthines (theophylline, theobromine, caffeine) and catecholamines].
Topics: Animals; Caffeine; Epinephrine; Female; Heart; Isoproterenol; Male; Myocardium; NAD; NADP; Norepinephrine; Rats; Stimulation, Chemical; Theobromine; Theophylline | 1975 |
Defects of glucose-6-phosphate and 6-phosphogluconate dehydrogenases in Neurospora and their pleiotropic effects.
Topics: Culture Media; Drug Stability; Enzyme Repression; Genetic Linkage; Glucosephosphate Dehydrogenase; Heterozygote; Kinetics; Linolenic Acids; Mutation; NAD; NADP; Neurospora; Neurospora crassa; Pentosephosphates; Phenotype; Phosphogluconate Dehydrogenase; Theophylline | 1976 |
Cyclic AMP-dependent control of the rat hepatic glutathione disulfide-sulfhydryl ratio.
Topics: Amitrole; Animals; Bucladesine; Catalase; Circadian Rhythm; Cyclic AMP; Disulfides; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Liver; Liver Glycogen; NADP; Organ Size; Proteins; Rats; Starvation; Sulfhydryl Compounds; Theophylline | 1977 |
The stimulus-secretion coupling of glucose-induced insulin release. Metabolic events in islets stimulated by non-metabolizable secretagogues.
Topics: Adenine Nucleotides; Animals; Barium; Calcium; Female; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; NAD; NADP; Rats; Theophylline; Uncoupling Agents | 1979 |
Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.
Topics: Aniline Compounds; Animals; Biotransformation; Bucladesine; Cyclic AMP; Cytochrome P-450 Enzyme System; Depression, Chemical; Glucagon; Glucosephosphate Dehydrogenase; Glucosephosphates; Hexobarbital; In Vitro Techniques; Liver; Male; Microsomes, Liver; NADP; Rats; Theophylline; Time Factors | 1972 |
An anomalous effect of theophylline on ACTH and adenosine 3',5'-monophosphate stimulation.
Topics: Adenine Nucleotides; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Glycine; Hexosephosphates; In Vitro Techniques; NADP; Protein Biosynthesis; Rats; Theophylline | 1966 |
The role of adenosine 3',5'-phosphate in mediating effects of thyroid-stimulating hormone on carbohydrate metabolism of bovine thyroid slices.
Topics: Adenine Nucleotides; Animals; Butyrates; Carbon Dioxide; Carbon Isotopes; Cattle; Cyclic AMP; Depression, Chemical; Glucose; In Vitro Techniques; Lactates; NADP; Pyruvates; Stimulation, Chemical; Theophylline; Thyroid Gland; Thyrotropin | 1968 |
Effect of cyclic 3',5'-AMP on glucose metabolism in thyroid homogenates.
Topics: Adenine Nucleotides; Animals; Carbon Dioxide; Carbon Isotopes; Cattle; Cyclic AMP; Glucose; In Vitro Techniques; NADP; Stimulation, Chemical; Theophylline; Thyroid Gland | 1969 |
Effect of pyridine nucleotide precursors on the permeability of toad bladder in the presence of vasopression, adenosine 3':5'-cyclic monophosphate, and theophylline.
Topics: Animals; Cell Membrane Permeability; Cyclic AMP; NAD; NADP; Theophylline; Urinary Bladder; Vasopressins; Water | 1970 |
Macromolecular synthesis is required for stimulation of estrogen synthetase activity by dibutyryl cyclic AMP plus theophylline in choriocarcinoma cell culture.
Topics: Aromatase; Bucladesine; Cells, Cultured; Choriocarcinoma; Cycloheximide; Dactinomycin; Estrogens; Female; Humans; Macromolecular Substances; NADP; NADPH-Ferrihemoprotein Reductase; Neoplasms, Experimental; Oxidoreductases; Pregnancy; Theophylline; Uterine Neoplasms | 1981 |
The role of old age in the effects of glucose on insulin secretion, pentosephosphate shunt activity, pyridine nucleotides and glutathione of rat pancreatic islets.
Topics: Aging; Animals; DNA; Female; Glucose; Glucose Tolerance Test; Glutathione; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; NAD; NADP; Oxidation-Reduction; Pentosephosphates; Rats; Rats, Inbred Strains; Theophylline | 1984 |
Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.
Topics: Animals; Calcium; Female; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; NAD; NADP; Rats; Rubidium; Sodium; Sulfonylurea Compounds; Theophylline; Tolbutamide | 1980 |
Characterization of the inhibition of P4501A2 by furafylline.
Topics: Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Microsomes, Liver; NADP; Oxidoreductases; Spectrophotometry, Ultraviolet; Theophylline | 1994 |
Pharmacological actions of the coenzymes NAD(H) and NADP(H) on the rat anococcygeus muscle.
Topics: Adenosine; Animals; Arginine; Electric Stimulation; Male; Muscle Contraction; Muscle Relaxation; NAD; NADP; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Theophylline | 1994 |
Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Chlorzoxazone; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes b5; Escherichia coli; Ethanolamines; Humans; Hydroxylation; Mixed Function Oxygenases; Mutation; NADP; Nifedipine; Oxidation-Reduction; Phospholipids; Recombinant Proteins; Testosterone; Theophylline; Tolbutamide; Warfarin | 1997 |
Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices.
Topics: Animals; Benzoflavones; Chlorzoxazone; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Enzyme Inhibitors; In Vitro Techniques; Liver; Male; Melatonin; Microsomes, Liver; Models, Molecular; NADP; Oxidation-Reduction; Rats; Rats, Wistar; Theophylline | 2001 |
Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine.
Topics: Anti-Arrhythmia Agents; Benzoflavones; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Humans; Hydroxylation; Kinetics; Mexiletine; Microsomes, Liver; Mitochondria, Liver; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Saccharomyces cerevisiae; Theophylline | 2003 |
Identification of the human cytochrome P450s responsible for the in vitro metabolism of a leukotriene B4 receptor antagonist, CP-195,543.
Topics: Adolescent; Adult; Aged; Chromans; Coumarins; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Humans; Ketoconazole; Kinetics; Male; Mephenytoin; Microsomes, Liver; Middle Aged; NADP; Oxidation-Reduction; Quinidine; Receptors, Leukotriene B4; Recombinant Proteins; Sulfaphenazole; Theophylline | 2003 |
Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.
Topics: Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Dioxins; Ditiocarb; Electron Transport; Enzyme Induction; Enzyme Inhibitors; Hydrogen Peroxide; Mice; Mice, Knockout; Microsomes, Liver; NADP; Oxidative Stress; Reactive Oxygen Species; Theophylline | 2004 |
Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?
Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dihydralazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Models, Biological; NADP; Paroxetine; Pyrazines; Resveratrol; Stilbenes; Theophylline; Thiones; Thiophenes | 2007 |
Salivary aldehyde dehydrogenase--reversible oxidation of the enzyme and its inhibition by caffeine, investigated using fluorimetric method.
Topics: Adult; Aldehyde Dehydrogenase; Aldehydes; Caffeine; Fluorometry; Glutathione; Humans; Kinetics; Middle Aged; NAD; NADP; Naphthalenes; Oxidation-Reduction; Saliva; Theophylline | 2008 |
Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
Topics: Antibodies; Aryl Hydrocarbon Hydroxylases; Biocatalysis; Biotransformation; Cell Line; Cell Line, Tumor; Clopidogrel; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Glutathione; Humans; Ketoconazole; Kinetics; Mephenytoin; Microsomes; Microsomes, Liver; NADP; Omeprazole; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Platelet Aggregation Inhibitors; Sulfaphenazole; Theophylline; Ticlopidine | 2010 |